blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2155672

EP2155672 - PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.09.2011
Database last updated on 16.11.2024
Most recent event   Tooltip27.09.2013Lapse of the patent in a contracting state
New state(s): TR		published on 30.10.2013  [2013/44]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2010/08]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / HAN, Bo
801 Yin Hua Road Building 11-1202 Pudong
Shanghai 201204 / CN
02 / KNUST, Henner
Im Ortsetter 26a
79618 Rheinfelden / DE
03 / NETTEKOVEN, Matthias
Ruetteweg 3
79639 Grenzach-wyhlen / DE
04 / RATNI, Hasane
Louis Pasteur 4
F-68440 Habsheim / FR
05 / WU, Xihan
Room 1101, No. 2, Building 12, Jinmao Garden Luxiying
Nanjing 210031 / CN
 [2010/32]
Former [2010/08]01 / HAN, Bo
801 Yin Hua Road Building 11-1202 Pudong
Shanghai 201204 / CN
02 / KNUST, Henner
Im Ortsetter 26a
79618 Rheinfelden / DE
03 / NETTEKOVEN, Matthias
Ruetteweg 3
79639 Grenzach-wyhlen / DE
04 / RATNI, Hasane
Louis Pasteur 4
F-68440 Habsheim / FR
05 / WU, Xihan
Apartment 8-902 Jinan East Road
Shanghai 201204 / CN
Representative(s)Poppe, Regina
F.Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2010/08]Poppe, Regina
F.Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date08760181.129.05.2008
[2010/08]
WO2008EP56589
Priority number, dateEP2007010978107.06.2007         Original published format: EP 07109781
[2010/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008148689
Date:11.12.2008
Language:EN
[2008/50]
Type: A1 Application with search report 
No.:EP2155672
Date:24.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 11.12.2008 takes the place of the publication of the European patent application.
[2010/08]
Type: B1 Patent specification 
No.:EP2155672
Date:27.10.2010
Language:EN
[2010/43]
Search report(s)International search report - published on:EP11.12.2008
ClassificationIPC:C07D207/16, C07D401/06, C07D487/10, A61P25/16, A61P25/18, A61K31/401
[2010/08]
CPC:
C07D207/16 (EP,US); A61P25/00 (EP); A61P25/04 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P43/00 (EP); C07D401/06 (EP,US);
C07D471/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/08]
TitleGerman:PROLINAMIDDERIVATE ALS NK3-ANTAGONISTEN[2010/08]
English:PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS[2010/08]
French:DÉRIVÉS DE PROLINAMIDE CONVENANT COMME ANTAGONISTES DE NK3[2010/08]
Entry into regional phase07.01.2010National basic fee paid 
07.01.2010Designation fee(s) paid 
07.01.2010Examination fee paid 
Examination procedure07.01.2010Examination requested  [2010/08]
09.02.2010Amendment by applicant (claims and/or description)
17.05.2010Communication of intention to grant the patent
13.09.2010Fee for grant paid
13.09.2010Fee for publishing/printing paid
Opposition(s)28.07.2011No opposition filed within time limit [2011/40]
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
HR27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
PL27.10.2010
RO27.10.2010
SI27.10.2010
SK27.10.2010
TR27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
LU29.05.2011
MC31.05.2011
[2013/44]
Former [2013/26]CY27.10.2010
CZ27.10.2010
DK27.10.2010
EE27.10.2010
HR27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
PL27.10.2010
RO27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
LU29.05.2011
MC31.05.2011
Former [2013/25]CZ27.10.2010
DK27.10.2010
EE27.10.2010
HR27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
PL27.10.2010
RO27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
LU29.05.2011
MC31.05.2011
Former [2012/05]CZ27.10.2010
DK27.10.2010
EE27.10.2010
HR27.10.2010
LT27.10.2010
LV27.10.2010
MT27.10.2010
PL27.10.2010
RO27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
MC31.05.2011
Former [2011/38]CZ27.10.2010
DK27.10.2010
EE27.10.2010
HR27.10.2010
LT27.10.2010
LV27.10.2010
PL27.10.2010
RO27.10.2010
SI27.10.2010
SK27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
Former [2011/29]HR27.10.2010
LT27.10.2010
LV27.10.2010
SI27.10.2010
BG27.01.2011
NO27.01.2011
GR28.01.2011
IS27.02.2011
PT28.02.2011
Cited inInternational search[A]WO2004056799  (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-21 * page 7; compound I *;
 [A]  - WALPOLE C ET AL, "2-NITROPHENYLCARBAMOYL-(S)-PROLYL-(S)-3-(2-NAPHTHYL)ALANYL-N-BENZYL-N- METHYLAMIDE (SDZ NKT 343), A POTENT HUMAN NK1 TACHYKININ RECEPTOR ANTAGONIST WITH GOOD ORAL ANALGESIC ACTIVITY IN CHRONIC PAIN MODELS", JOURNAL OF MEDICINAL CHEMISTRY, USAMERICAN CHEMICAL SOCIETY. WASHINGTON, (19980813), vol. 41, no. 17, ISSN 0022-2623, pages 3159 - 3173, XP000972902 [A] 1-21 * page 3161; compound 3A *

DOI:   http://dx.doi.org/10.1021/jm970499g
 [A]  - GIARDINA GAM ET AL, "Recent advances in neurokinin-3 receptor antagonists", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, (20000101), vol. 10, no. 6, ISSN 1354-3776, pages 939 - 960, XP002349355 [A] 1-21 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.10.6.939
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.